Teladoc Health (TDOC) Liabilities and Shareholders Equity (2014 - 2026)

Teladoc Health has disclosed Liabilities and Shareholders Equity across 13 years of filings, most recently posting $2.8 billion for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 4.68% year-over-year to $2.8 billion; the TTM figure through Jun 2026 stood at $11.3 billion (down 15.55% YoY), while the FY2025 annual figure was $2.9 billion, down 18.72% from the prior year.
• Liabilities and Shareholders Equity came in at $2.8 billion for Q2 2026 at Teladoc Health, down from $2.8 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $11.1 billion in Q1 2022 to a low of $2.8 billion in Q2 2026.
• Average Liabilities and Shareholders Equity over 5 years is $4.5 billion, with a median of $3.9 billion recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity plunged 75.5% in 2022 and climbed 1.08% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then climbed by 1.08% to $4.4 billion in 2023, then fell by 19.94% to $3.5 billion in 2024, then slipped by 18.72% to $2.9 billion in 2025, then slipped by 3.49% to $2.8 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $2.8 billion in Q2 2026, $2.8 billion in Q1 2026, and $2.9 billion in Q4 2025.